leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 21:57:14 - browse：4

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： The explosion of genetic testing requires a new approach

entertainment

WSS

Federal weight loss drug coverage is 30 years out of date

Why health workers in Gaza are injured or die at high rates

Researchers explore possible ties between long Covid, menopause

Goldman Sachs launches $650M fund for life science investments

Why psychiatrists like me stop taking insurance

Videos point to link between seizures and unexplained toddler deaths

focus

leisure time

Wikipedia

How to save PrEP access — and even expand it

Morgan Health, with ambitious aims, wants you to know it’s still here

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How a scoliosis diagnosis changed the life of one young dancer

Alkermes shareholders re

HHS leader on health, climate change and biopharma emissions

Psychedelics group wrestles with new pharma identity

GSK Flovent asthma inhalers replaced by authorized generics

knowledge

AdventHealth escalates lawsuit against insurance vendor Multiplan

Federal weight loss drug coverage is 30 years out of date

Senate committee scrutinizes Medicare Advantage brokers

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Eli Lilly expects to double planned employment in Boston center

NIH confirmation hearing shows politicization of research

knowledge

entertainment

hotspot

explore